Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozole-Reference-Cited by-同舟云学术

Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozole

Published:2018-12-25 Issue:6 Volume:11 Page:762-771
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Favretto Donata¹²,Snenghi Rossella¹,Pertile Roberto¹,El Mazloum Rafi²,Tucci Marianna²,Visentin Sindi¹²^ORCID,Vogliardi Susanna²

Affiliation:

1. University Hospital of Padova Padova Italy

2. Department of Cardiac Thoracic and Vascular Sciences and Public HealthUniversity of Padova Padova Italy

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2555

Reference39 articles.

1. Personalizing aromatase inhibitor therapy in patients with breast cancer

2. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer

3. Micellar Electrokinetic Chromatographic Study of the Separation of an Aromatase Inhibitor and a Tryciclic Antidepressant in the Breast Cancer Treatment

4. Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry

5. Food and Drug Administration (FDA).AROMASIN® (exemestane) tablets. FDA‐approved patient labeling.https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020753s006lbl.pdf. Accessed September 17 2018.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowing the minimal detectable dose can facilitate the interpretation of a hair test result: Case example with chlortalidone;Clinica Chimica Acta;2024-08

2. Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established;Drug Testing and Analysis;2024-08

3. Reply to the paper of Breuer et al.: complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact—a case report;Forensic Toxicology;2024-06-27

4. Violation des règles antidopage et contamination. Stratégie de défense des athlètes à partir d’une analyse de cheveux et considérations générales;Toxicologie Analytique et Clinique;2024-06

5. Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti‐doping rule violation. IV. Case example with mesterolone;Drug Testing and Analysis;2024-03-14